Novolin R (recombinant human insulin) / Novo Nordisk |
2005-001693-27: Pilot Effectiveness of Randomised Mandatory Insulin Therapy |
|
|
| Ongoing | 4 | 120 | Europe | ACTRAPID, ACTRAPID, ACTRAPID, ACTRAPID | Oxford Radcliffe Hospitals NHS Trust | Those admitted to the Intensive Care Unit for treatment and likely to remain on the unit for longer than 5 days. | | | | |
2006-005817-36: Ensayo Clínico en fase IV para la comparación entre dos pautas de tratamiento (insulina humana vs análogos de insulina) respecto al riesgo de hipoglicemia y la variabilidad del control glicémico en pacientes con diabetes mellitus tipo 1: impacto sobre el HYPO score y el LI (lability index). |
|
|
| Ongoing | 4 | 70 | Europe | Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid, Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid, Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid | Dr Manuel Pérez Maraver.Servicio de Endocrinologia. Hospital de Bellvitge | Diabetes mellitus tipo 1. Variabilidad del control glicémico y riesgo de hipoglicemia con una pauta de insulina basada en analogos respecto a una con insulina humana. | | | | |
2007-001590-29: Insulin aspart (NovoRapid®, Novo Nordisk) vs. human insulin (Actrapid®, Novo Nordisk) in intravenous treatment of high blood glucose concentrations in the ICU |
|
|
| Ongoing | 4 | 50 | Europe | NovoRapid, Actrapid, NovoRapid®,, Actrapid®, NovoRapid®,, Actrapid® | Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin | Therapy of hyperglycemia by intravenously applied insulin is going to be investigated.Hyperglycemia is very common in hospitalized, critically ill patients, even if they have not previously had diabetes. Studies have established that in-hospital hyperglycemia is associated with higher mortality and morbidity. Therefore, careful monitoring and therapy of hyperglycemia have become standard in the ICU and include treatment with continuous infusion of insulin. | | | | |
2007-000223-17: PRACDICAL StudyPrevention and Risk factors of Arterial Complications in DIabetics after non-CArdiac surgicaL interventions |
|
|
| Ongoing | 4 | 2000 | Europe | Actrapid HM , Novo Nordisk, Copenhagen, Denmark, EU/1/02/230/004, Actrapid HM 1000 IE/10 ml, Novo Nordisk, Copenhagen, Denmark Reg name: Actrapid 100 IE/ml, Actrapid HM 1000 IE/10 ml, Novo Nordisk, Copenhagen, Denmark Reg name: Actrapid 100 IE/ml | M.S. Arbous | Diabetes Mellitus | | | | |
| Ongoing | 4 | 16 | Europe | Detemir (Levemir®), NPH insulin (Insulatard®), Actrapid, EU/1/04/278/005, EU/1/02/233/003, Actrapid 100 IU/ml EU/1/02/230/003, Insulin detemir, Human insulin NPH insulatard, Insulin actrapid, Insulin detemir, Human insulin NPH insulatard, Insulin actrapid | University of Surrey, Flinders University | Obstructive sleep apnoea | | | | |
2011-003221-97: Beneficios del tratamiento intensivo con insulina de las subidas de azúcar asociadas a las enfermedades graves (de UCIP) de los niños |
|
|
| Ongoing | 4 | 204 | Europe | Actrapid HM, ACTRAPID HM, ACTRAPID HM | Fundacio Sant Joan de Deu, Fundacio Sant Joan de Deu | Nuestra hipotesis es que el tratamiento intensivo con insulina endovenosa de la hiperglucemia asociada a las patologías críticas del paciente pediátrico mejora el pronóstico de las mismas | | | | |
2011-006179-20: Comparative randomized clinical trial between insulin analogues and human insulin in hospitalized patients treated with artificial tube feeding and who present high blood glucose levels. INSULINE study. Ensayo clínico aleatorizado comparativo entre análogos de insulina e insulina humana en pacientes hospitalizados tratados con alimentación artificial por sonda y que presentan niveles elevados de glucosa en sangre. Estudio INSULINE. |
|
|
| Ongoing | 4 | 100 | Europe | Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen, Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen | Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge., Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge. | Pacients receiving enteral nutrition and who present hyperglycemia. Pacientes tratados con nutrición enteral y que presenten hiperglicemia. | | | | |
2014-002341-22: Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients. Untersuchung der Wirkung von Glukagon-Präparaten auf den Glukosespiegel im Fettgewebe bei Patienten mit Typ 1 Diabetes. |
|
|
| Ongoing | 4 | 10 | Europe | Glucagon FOR INJECTION (rDNA ORIGIN), Eli Lilly Glucagon, GlucaGen, GLUCAGON FOR INJECTION (rDNA ORIGIN), NovoRapid, Actrapid, GlucaGen, GLUCAGON FOR INJECTION (rDNA ORIGIN), NovoRapid, Actrapid | Medizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel, Medizinische Universität Graz; Universitätsklinik für Innere Medizin; Abteilung für Endokrinologie und Stoffwechsel | Diabetes Mellitus type 1 | | | | |
2004-004348-39: Effect of Strict Control of Blood Sugar with Insulin Regimen on Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting. |
|
|
| Ongoing | 4 | 240 | Europe | Actrapid, Actrapid, Actrapid | Royal Brompton & Harefield NHS Trust | Atrial Fibrillation following Coronary Artery Bypass Grafting operation. | | | | |
2018-003557-21: Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetes |
|
|
| Not yet recruiting | 4 | 40 | Europe | Lantus, Actrapid, Solution for injection in pre-filled pen, Nasal spray, Suliqua®, Lantus® | University Hospital Tuebingen, Sanofi-Aventis Deutschland GmbH | Female and male subjects with type 2 diabetes, Body processes [G] - Metabolic Phenomena [G03] | | | | |
2021-006801-31: CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE I ENSAYO CLÍNICO PARA DETERMINAR LA EFICACIA Y SEGURIDAD DEL COLIRIO DE INSULINA EN EL TRATAMIENTO DEL OJO SECO |
|
|
| Not yet recruiting | 4 | 120 | Europe | Actrapid, CICLOSPORINA A | Barbara Burgos-Blasco, Hospital Clinico San Carlos | Dry eye disease Enfermedad del ojo seco, Dry eye disease Ojo seco, Diseases [C] - Eye Diseases [C11] | | | | |
2022-002434-13: CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE IN GLAUCOMA ENSAYO CLÍNICO PARA DETERMINAR LA EFICACIA Y SEGURIDAD DEL COLIRIO DE INSULINA EN EL TRATAMIENTO DEL OJO SECO EN GLAUCOMA |
|
|
| Not yet recruiting | 4 | 100 | Europe | Actrapid | Barbara Burgos-Blasco, Hospital Clinico San Carlos | Dry eye disease in glaucoma Enfermedad del ojo seco en el glaucoma, Dry eye disease Ojo seco, Diseases [C] - Eye Diseases [C11] | | | | |
2006-001254-27: Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus |
|
|
| Ongoing | 3 | 37 | Europe | NovoNorm 0.5 mg, Actrapid Penfill 100UI/ml, NovoNorm 1 mg, NovoNorm 2 mg, NovoNorm 0.5 mg, Actrapid Penfill 100UI/ml, NovoNorm 1 mg, NovoNorm 2 mg, NovoNorm 0.5 mg, Actrapid Penfill 100UI/ml, NovoNorm 1 mg, NovoNorm 2 mg | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | Patients atteints de mucoviscidose, chez lesquels un diagnostic de diabète a été fait par hyperglycémie provoquée orale (HGPO) | | | | |
2010-022246-25: Diagnostic clinique et mécanismes physiopathologiques de l'allergie à l'insuline. |
|
|
| Not yet recruiting | 3 | 70 | Europe | Actrapid, Insulatard, Insuman Infusat, Humalog, NovoRapid, Apidra, Lantus, Levemir, Latex, Solution for injection, Suspension for injection, Solution for infusion, Actrapid, Insulatard, Novorapid, Levemir | | Allergie à l'insuline | | | | |
2016-001401-16: The SUGAR-DIP trial: Oral medication versus insulin for diabetes in pregnancy De SUGAR-DIP trial: Orale medicatie versus insuline voor zwangerschapsdiabetes |
|
|
| Ongoing | 3 | 810 | Europe | Metformin, Glibenclamide, Tablet, Injection, Metformin, Glibenclamide, Insulin: including - fast acting, analog: NovoRapid, Humalog, Apidra - short acting, human: Actrapid, Humuline Regular, Insuman Rapid - medium long acting, human: Insulatard, Humuline NPH, Insuman Basal - long acting analog: Lantus, Levemir | University Medical Center Utrecht, ZonMw | The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment. In deze trial wordt het ziektebeeld diabetes gravidarum onderzocht, waarbij er met dieetaanpassingen onvoldoende glucosecontrole is bereikt en er dus indicatie is voor aanvullende farmacologische behandeling., Gestational diabetes, also known as gestational diabetes mellitus, is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy. Zwangerschapssuikerziekte, ook wel zwangerschapsdiabetes, is een aandoening waarbij vrouwen waarbij niet al eerder suikerziekte is vastgesteld, tijdens de zwangerschap hoge bloedsuikerwaardes hebben., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
| Not yet recruiting | 2/3 | 30 | US | Human Insulin, Humulin(R), Novolin(R), Finger-actuated, Metered Pump Sprayer | Transdermal Delivery Solutions Corp, Langford Research Institute, Inc. | Glucose, High Blood | 10/25 | 12/25 | | |
NCT00214916: Tight Glycemic Control With Intensive Insulin Therapy in PICU |
|
|
| Active, not recruiting | 2 | 700 | Europe | intensive insulin therapy (Actrapid IV to normoglycemia), Actrapid IV to normoglycemia, conventional insulin therapy (Actrapid IV only for excessive hyperglycemia), Actrapid IV only for excessive hyperglycemia | Greet Van den Berghe | Critical Illness | 02/08 | 06/23 | | |
2005-004753-95: A Phase II, Dose Ranging Single Centre, Single Blind, Parallel-group, Controlled Study of the Safety, Tolerability and Effects on Metabolic Control of an Oral Insulin Formulation in a Type II Diabetic Population |
|
|
| Ongoing | 2 | 16 | Europe | Capsulin 150iu, Actrapid, DTY001, Actrapid, Actrapid | Diabetology Ltd | Type II Diabetes | | | | |
2017-002553-11: Cardiovascular effects of Insulin Insulin - effekter på hjerte og kredsløb |
|
|
| Not yet recruiting | 2 | 10 | Europe | Actrapid, Concentrate for solution for infusion, Actrapid | Bispebjerg Hospital, University of Copenhagen, University of Copenhagen | Insulin-induced increased heart rate, blood pressure and cardiacoutput Insulin induceret stigning i puls, blodtryk og minutvolumen, Changes in heart rate, blood pressure, and cardiac function caused byinsulin. Insulins ændringer i puls, blodtryk og hjertes pumpefunktion, Diseases [C] - Injuries, poisonings, and occupational diseases [C21] | | | | |
| Active, not recruiting | 2 | 30 | US | Regular Novolin R, Placebo | HealthPartners Institute | Parkinson Disease | 08/24 | 02/25 | | |
NCT03943537: Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders |
|
|
| Recruiting | 2 | 90 | US | Intranasal Insulin, Novolin R | Mclean Hospital | Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder | 01/24 | 01/24 | | |
NCT06770608: Various Procedural Treatment Options for Post-acne Atrophic Scars |
|
|
| Not yet recruiting | 2 | 60 | RoW | micro-needling with topical human actrapid insulin, Micro-needling with topical Platelet rich plasma | Sheikh Zayed Medical College | Post-acne Atrophic Scars | 04/25 | 04/25 | | |
| Recruiting | 2 | 80 | RoW | Semaglutide, Rybelsus, Intranasal insulin, Actrapid, Semaglutide placebo, Intranasal insulin placebo | Rutgers, The State University of New Jersey, Alzheimer's Association | Alzheimer Disease, Mild Cognitive Impairment, Metabolic Syndrome | 12/27 | 12/28 | | |
| Recruiting | 1/2 | 40 | US | Regular Human Insulin then Placebo, Novolin R, Placebo then Regular Human Insulin | Brown University | Alcohol Use Disorder | 03/25 | 03/25 | | |
| Completed | 1 | 40 | US | Insulin, Regular, Human, Novolin R, Placebo, Saline | Pennington Biomedical Research Center, Nutrition Obesity Research Center | Insulin | 06/22 | 06/22 | | |
INI-CSF, NCT05866367: Measurement of Insulin Levels in Cerebral Spinal Fluid (CSF) of Healthy Adults After a Single Intranasal Dose |
|
|
| Suspended | 1 | 12 | US | Low dose Regular Insulin, Novolin-R, High dose Regular insulin | HealthPartners Institute | Healthy | 08/25 | 11/25 | | |
| Withdrawn | 1 | 16 | US | Insulin human, Novolin-R, Humulin-R, Octreotide Acetate, Octreotide Acetate IV, Glucagon, Glucagon IV, Human Growth Hormone, Omnitrope, Dexamethasone Oral, Dexamethasone, [6,6-2H2] D-glucose, D2-glucose, D2G, 20% D-glucose (aq), D20W, BOOST Plus, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer, Normal saline, NaCl IV, Human albumin, Human albumin IV | Columbia University, Albert Einstein College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease, Overweight and Obesity | 11/25 | 03/26 | | |
INI-CSF-MA, NCT06434038: Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age |
|
|
| Not yet recruiting | 1 | 18 | US | Low Dose Regular insulin, Novolin-R, High Dose Regular insulin, 0.9% Saline | HealthPartners Institute, United States Department of Defense, Uniformed Services University of the Health Sciences | Healthy | 02/26 | 02/26 | | |
NCT06558422: Human Models of Selective Insulin Resistance: Pancreatic Clamp |
|
|
| Not yet recruiting | 1 | 36 | US | Insulin human, Novolin-R, Humulin-R, Octreotide Acetate, Glucagon, Growth Hormone, Human, Omnitrope, Zomacton, 20% D-glucose (aq), D20W, [6,6-2H2] D-glucose, D2-glucose, D2G, [1-13C1] sodium acetate, 13C-acetate, C13A, Nestle BOOST Plus, KIND Bar, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer | Columbia University, University of California, Berkeley, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity | 12/27 | 02/28 | | |
| Active, not recruiting | N/A | 60 | Europe | insulin human, Actrapid, Epinephrin, Adrenalin, Muscle biopsy, Adipose tissue biopsy, Glucagon, GlucaGen, IPRO 2 Medtronic Minimed, Blinded Continuous Glucose Monitoring, 7 Tesla (7T) Magnetic Resonance Imaging, 7T MRI, Indirect Calorimetry using Jaeger Oxycon Champion, Core temperature and thermography using Thermovision SC645, Freestyle Libre 2, Intermittently scanned continuous glucose monitor | Nordsjaellands Hospital, Danish Research Centre for Magnetic Resonance, University of Copenhagen, Steno Diabetes Center Copenhagen | Type1diabetes | 12/23 | 12/23 | | |
| Recruiting | N/A | 24 | | | NW Cheung | Diabetes mellitus | | | | |